Drugs Made In America Acquisition Corpの主要な財務諸表は何ですか?
DMAAUの主要な財務比率は何ですか?
Drugs Made In America Acquisition Corpの収益はセグメントまたは地域別にどのように分けられていますか?
Drugs Made In America Acquisition Corpは収益を上げていますか?
Drugs Made In America Acquisition Corpに負債はありますか?
Drugs Made In America Acquisition Corpの発行済株式数は何株ですか?
主要データ
前終値
$10.55
始値
$10.55
当日レンジ
$10.55 - $10.55
52週レンジ
$10 - $10.82
取引高
16
平均取引高
6.2K
1株当たり利益(TTM)
0.20
配当利回り
--
時価総額
$353.6M
DMAAUとは何ですか?
Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-01-28. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenues.